A. ÖZKAN Et Al. , "Effect of prophylactic beta-glucan use on the incidence of neutropenic fever and survival rates in pediatric patients with sarcoma," CUKUROVA MEDICAL JOURNAL , vol.47, no.2, pp.596-602, 2022
ÖZKAN, A. Et Al. 2022. Effect of prophylactic beta-glucan use on the incidence of neutropenic fever and survival rates in pediatric patients with sarcoma. CUKUROVA MEDICAL JOURNAL , vol.47, no.2 , 596-602.
ÖZKAN, A., KÜPELİ, S., Cil, M., SEZGİN, G., & BAYRAM, İ., (2022). Effect of prophylactic beta-glucan use on the incidence of neutropenic fever and survival rates in pediatric patients with sarcoma. CUKUROVA MEDICAL JOURNAL , vol.47, no.2, 596-602.
ÖZKAN, AYŞE Et Al. "Effect of prophylactic beta-glucan use on the incidence of neutropenic fever and survival rates in pediatric patients with sarcoma," CUKUROVA MEDICAL JOURNAL , vol.47, no.2, 596-602, 2022
ÖZKAN, AYŞE Et Al. "Effect of prophylactic beta-glucan use on the incidence of neutropenic fever and survival rates in pediatric patients with sarcoma." CUKUROVA MEDICAL JOURNAL , vol.47, no.2, pp.596-602, 2022
ÖZKAN, A. Et Al. (2022) . "Effect of prophylactic beta-glucan use on the incidence of neutropenic fever and survival rates in pediatric patients with sarcoma." CUKUROVA MEDICAL JOURNAL , vol.47, no.2, pp.596-602.
@article{article, author={AYŞE ÖZKAN Et Al. }, title={Effect of prophylactic beta-glucan use on the incidence of neutropenic fever and survival rates in pediatric patients with sarcoma}, journal={CUKUROVA MEDICAL JOURNAL}, year=2022, pages={596-602} }